Chemours (CC) Cost of Revenue (2014 - 2026)

Chemours has reported Cost of Revenue for 13 years, with the latest figure at $1.3 billion in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 2.39% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $4.9 billion, a 2.61% increase from a year earlier, with the FY2025 full-year figure at $4.9 billion, up 5.73% from the prior year.
• Cost of Revenue was $1.3 billion for Q2 2026 at Chemours, up from $1.2 billion in the prior quarter.
• The five-year high for Cost of Revenue was $1.4 billion in Q2 2022, with the low at $1.1 billion in Q1 2024.
• Average Cost of Revenue over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue rose 12.2% in 2022, then dropped 11.85% in 2023.
• Over 5 years, Cost of Revenue stood at $1.1 billion in 2022, then fell by 2.11% to $1.1 billion in 2023, then retreated by 1.71% to $1.1 billion in 2024, then gained by 7.31% to $1.2 billion in 2025, then advanced by 11.16% to $1.3 billion in 2026.
• The last three Cost of Revenue figures came in at $1.3 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.